Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1547575

registered interest
date	02/12/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Stevens-Johnson Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 30 November 2022 to Question 96551 on Stevens-Johnson Syndrome and the oral contribution by the then-Parliamentary Under Secretary of State for Life Sciences, Official Report, 13 July 2016, column 135WH, for what reason the information which enabled the then Parliamentary Under Secretary of State to state that Stevens-Johnson Syndrome affects about 150 patients a year is no longer available; from where such information can now be obtained; and for what reason the MHRA has not shared with the Minister the information given by its vigilance and risk management team on 4 August 2021 in response to FOI request 21/798 on the number of reports of Stevens-Johnson Syndrome in relation to covid-19 up to 14 July 2021.
tabling member constituency	Christchurch
tabling member printed	Sir Christopher Chope
uin	101687
answer	answer is ministerial correction date of answer 21/12/2022 answer text <p>The information provided in 2016 was obtained from an audit undertaken at that time. NHS England does not routinely collect or review data identifying numbers of patients diagnosed with Stevens-Johnson Syndrome.</p><p>The Medicines and Healthcare products Regulatory Agency (MHRA) continually monitors safety during the widespread use of a vaccine. The MHRA also works with public health partners to review the effectiveness and impact of vaccines to ensure the benefits continue to outweigh any possible side effects. The MHRA routinely updates the Department on COVID-19 vaccine safety.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 21/12/2022 17:06:28 answering member 4492 label Biography information for Maria Caulfield previous answer version 40433 answering member constituency Lewes answering member printed Maria Caulfield answering member 4492 label Biography information for Maria Caulfield
tabling member	242 label Biography information for Sir Christopher Chope

1545718

registered interest
date	25/11/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Stevens-Johnson Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many cases of Stevens-Johnson Syndrome were diagnosed by the NHS in England in (a) 2019, (b) 2020 and (c) 2021; whether any of these cases were linked to covid-19 vaccines; and what information her Department has provided to the public about whether people affected by Stevens-Johnson Syndrome should receive covid-19 booster vaccines.
tabling member constituency	Christchurch
tabling member printed	Sir Christopher Chope
uin	96551
answer	answer is ministerial correction date of answer 30/11/2022 answer text <p>The information requested is not collected centrally.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 30/11/2022 10:30:11 answering member 4492 label Biography information for Maria Caulfield
tabling member	242 label Biography information for Sir Christopher Chope

385003

registered interest
date	23/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Stevens-Johnson Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many instances of Stevens-Johnson Syndrome and toxic epidermal necrolysis have been reported in each of the last five years; and in how many of those cases were (a) paracetamol, (b) codeine and (c) other drugs were assessed to be the cause.
tabling member constituency	Barking
tabling member printed	Margaret Hodge
uin	3692
answer	answer is ministerial correction date of answer 30/06/2015 answer text <p>Reports of suspected adverse drug reactions (ADRs) are collected by the Medicines and Healthcare products Regulatory Agency (MHRA) and Commission for Human Medicines (CHM) through the spontaneous reporting scheme; the Yellow Card Scheme. The scheme collects ADR reports from across the United Kingdom on all medicines, including those from prescriptions, over-the-counter or general retail sales. Reports are also received for herbal medicines and other unlicensed medicines. Reporting to the Yellow Card Scheme is voluntary for healthcare professionals and members of the public, there is also a legal obligation for pharmaceutical companies to report all serious ADRs for their products that they are made aware of.</p><p> </p><p> </p><p> </p><p>There is an unknown and variable level of under-reporting to the Yellow Card Scheme meaning that data collected cannot be used to calculate incidence. We are unable to calculate this because neither the total number of reactions occurring in the population, nor the number of patients using the drug is known.</p><p> </p><p><strong> </strong></p><p> </p><p>Up to 22 June 2015, the MHRA has received a total of 262 UK spontaneous suspected ADR reports of Stevens-Johnson Syndrome (SJS) and 135 UK spontaneous suspected ADR reports of Toxic Epidermal Necrolysis (TEN) between 1 January 2011 and 31 December 2014.</p><p> </p><p><strong> </strong></p><p> </p><p>The table below shows the total number of UK spontaneous Stevens-Johnson Syndrome ADR reports received by the MHRA between 1 January 2011- 22 June 2015 associated with paracetamol, codeine and all other drugs.</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>Year</p></td><td><p>Paracetamol</p></td><td><p>Codeine</p></td><td><p>Other drugs not containing paracetamol or codeine</p></td></tr><tr><td><p>2011</p></td><td><p>0</p></td><td><p>0</p></td><td><p>50</p></td></tr><tr><td><p>2012</p></td><td><p>3</p></td><td><p>0</p></td><td><p>50</p></td></tr><tr><td><p>2013</p></td><td><p>0</p></td><td><p>0</p></td><td><p>68</p></td></tr><tr><td><p>2014</p></td><td><p>0</p></td><td><p>0</p></td><td><p>65</p></td></tr><tr><td><p>2015</p></td><td><p>0</p></td><td><p>0</p></td><td><p>26</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>The table below shows the total number of UK spontaneous Toxic Epidermal Necrolysis ADR reports received by the MHRA between 1 January 2011- 22 June 2015 associated with paracetamol, codeine and all other drugs.</p><p> </p><p><strong> </strong></p><p> </p><table><tbody><tr><td><p>Year</p></td><td><p>Paracetamol</p></td><td><p>Codeine</p></td><td><p>Other drugs not containing paracetamol or codeine</p></td></tr><tr><td><p>2011</p></td><td><p>0</p></td><td><p>0</p></td><td><p>19</p></td></tr><tr><td><p>2012</p></td><td><p>0</p></td><td><p>0</p></td><td><p>43</p></td></tr><tr><td><p>2013</p></td><td><p>1*</p></td><td><p>1*</p></td><td><p>26</p></td></tr><tr><td><p>2014</p></td><td><p>0</p></td><td><p>1</p></td><td><p>36</p></td></tr><tr><td><p>2015</p></td><td><p>0</p></td><td><p>0</p></td><td><p>9</p></td></tr></tbody></table><p> </p><p><strong> </strong></p><p> </p><p>*Refers to a case with co-codamol, so appears in both columns</p><p> </p><p> </p><p> </p><p>It is important to note that Yellow Card reports are not proof of a side effect occurring but only a suspicion by the reporter that the medicine may have caused the side effect. Yellow Card reports may therefore relate to true side effects of the medicine, or they may be due to coincidental illnesses that would have occurred in the absence of medicine.</p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 30/06/2015 14:01:33 answering member 4020 label Biography information for George Freeman
tabling member	140 label Biography information for Baroness Hodge of Barking

385009

registered interest
date	23/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Stevens-Johnson Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking to ensure that NHS staff are aware of the symptoms and treatment of Stevens-Johnson Syndrome and toxic epidermal necrolysis.
tabling member constituency	Barking
tabling member printed	Margaret Hodge
uin	3690
answer	answer is ministerial correction date of answer 30/06/2015 answer text <p>There are between 6,000 and 8,000 recognised rare diseases and an estimated 1 in 17 people will be affected by a rare disease at some point in their lifetime. The Government continues to work hard to raise awareness of, and take action on, rare diseases.</p><p> </p><p> </p><p> </p><p>In 2013, the Department published the UK Strategy for Rare Diseases. As part of its implementation, the Department has funded the production of two videos on rare diseases, the first from the viewpoint of the patient and their family and the second directed at healthcare professionals. The videos can be viewed on the Department’s website at:</p><p> </p><p> </p><p> </p><p><a href="https://www.gov.uk/government/collections/rare-diseases" target="_blank">https://www.gov.uk/government/collections/rare-diseases</a></p><p> </p><p> </p><p> </p><p>The Deputy Chief Medical Officer for England, Dr Gina Radford, a rare disease champion, raises the profile of rare diseases and their importance in healthcare planning. The Department is also working with Public Health England which is leading the establishment of the first UK Rare Disorders Register. This will eventually register all cases of rare disease in the United Kingdom.</p><p> </p><p> </p><p> </p><p>British National Formulary publishes guidance on Stevens Johnson Syndrome, including details of specific genetic testing.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 30/06/2015 12:58:26 answering member 4020 label Biography information for George Freeman
tabling member	140 label Biography information for Baroness Hodge of Barking